Action to protect the independence and integrity of global health research. by Storeng, KT et al.
 1Storeng KT, et al. BMJ Global Health 2019;4:e001746. doi:10.1136/bmjgh-2019-001746
Action to protect the independence and 
integrity of global health research
Katerini T Storeng,   1,2 Seye Abimbola,3 Dina Balabanova,4 David McCoy,5 
Valery Ridde,   6 Veronique Filippi,2 Sidsel Roalkvam,1 Grace Akello,7 
Melissa Parker,4 Jennifer Palmer,4 on behalf of the signatories
Editorial
To cite: Storeng KT, Abimbola S, 
Balabanova D, et al. Action 
to protect the independence 
and integrity of global health 
research. BMJ Global Health 
2019;4:e001746. doi:10.1136/
bmjgh-2019-001746
Received 30 May 2019
Accepted 30 May 2019
1Centre for Development and 
the Environment, University of 
Oslo, Oslo, Norway
2Department of Infectious 
Disease Epidemiology, London 
School of Hygiene & Tropical 
Medicine, London, UK
3School of Public Health, 
University of Sydney, Sydney, 
New South Wales, Australia
4Department of Global Health 
and Development, London 
School of Hygiene & Tropical 
Medicine, London, UK
5Centre for Primary Care and 
Public Health, Queen Mary 
University London, London, UK
6Institute for Research on 
Sustainable Development (IRD), 
CEPED (IRD-Université deParis), 
Université de Paris, ERL INSERM 
SAGESUD, Paris, France
7Department of Mental Health, 
Faculty of Medicine, Gulu 
University, Gulu, Uganda
Correspondence to
Katerini T Storeng;  
 katerini. storeng@ sum. uio. no
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
InTroduCTIon
In a recent Viewpoint in the Lancet, some 
of us shared our experience of censorship 
in donor-funded evaluation research and 
warned about a potential trend in which 
donors and their implementing partners use 
ethical and methodological arguments to 
undermine research.1
Reactions to the Viewpoint—and lively 
debate at the 2018 Global Symposium on 
Health Systems Research—suggest that similar 
experiences are common in implementa-
tion and policy research commissioned by 
international donors to study and evaluate 
large-scale, donor-funded health interven-
tions and programmes, which are primarily 
implemented in low resource settings. ‘We 
all have the same stories’, was one of the first 
comments on the Viewpoint, followed by 
many private messages divulging instances of 
personal and institutional pressure, intimi-
dation and censorship following attempts to 
disseminate unwanted findings. Such pres-
sure comes from major donors and from 
international non-governmental organisa-
tions (NGOs) obliged to have an external 
assessment but who then maintain a high 
degree of confidentiality and control.
That such experiences are widespread 
reflects the deeply political nature of the 
field of ‘global health’ and the intercon-
nections between priority setting, policy 
making and project implementation, which 
sit within a broader set of deeply entrenched 
power structures.2 3 Researchers in this field 
routinely find themselves working within—
and studying—complex power relations and 
so experience challenges in negotiating their 
own position between interests of commis-
sioning agencies and funders, implementers 
and country governments, as well as those 
of their own research institutions and their 
partnerships with other researchers span-
ning high-income, middle-income and 
low-income countries.4–7 They often receive 
research funding from major donor agen-
cies like the UK Department of International 
Development (DFID), the US Agency for 
International Development (USAID), the 
Agence Française de Développement (AFD), 
UNITAID and the Bill and Melinda Gates 
Foundation,8 who commission evaluations for 
their own funded projects, even though they 
have a stake in results that demonstrate the 
success of a multibillion-dollar investment.
Effects of interference in the research and 
evaluation process are compounded by more 
subtle acts of self-censorship and data embel-
lishment that can arise as researchers become 
embroiled in what was recently called the 
global health ‘success cartel’.9 Their involve-
ment in a collective drive to demonstrate 
success can unintentionally ‘instil a fear of 
failure, stifle risk-taking and innovation, and 
lead to the fabrication of achievement’.9 For 
example, research that threatens the posi-
tion of powerful elites—such as research into 
high-level corruption—is lacking.10 Mean-
while, selective reporting of ‘unwelcome’ 
findings can be a way to avoid contractual 
terminations even though it undermines 
learning.1 11 12 Moreover, perverse incentives 
exist across the global health and devel-
opment sectors to use simplistic indica-
tors of success and bad or fudged data.13–15 
Donor agencies exacerbate the problem by 
distorting research findings to exaggerate 
their own successes.16–19
Researchers are responsible for conducting 
research ethically and with integrity. Yet, 
without strong and reliable institutional 
support, they are often in a vulnerable posi-
tion when faced with vested interests. What 
action is needed to avoid undermining inde-
pendent and critical research findings? What 
kind of institutional structures and practices 
might support researchers in dealing with the 
ethical and political dilemmas associated with 
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the dissemination of (potentially) contested research 
findings and evaluation results?
To start a discussion on ways forward, we invited input 
from an international network of global health, health 
systems and policy researchers from diverse disciplines. 
Below, we discuss suggestions, endorsed by more than 
200 researchers based in 40 different countries (see the 
full list of signatories below), on how the organisations 
that commission, undertake and publish research and 
evaluations can safeguard independence and integrity.
CommIssIonIng bodIes
In the first instance, those commissioning external 
research must enable conditions for independence. 
Commissioning agencies should be transparent about 
the purpose and principles of external evaluation and 
research to their implementing partners and should 
commit to upholding the principles of good research: 
ethical, methodologically sound and responsive to popu-
lation needs. They should specify in the grant contract to 
researchers that they can review and provide input but 
will not interfere in the design, data collection, analysis or 
dissemination of any findings and that they fully commit 
to making all findings publicly available, whatever their 
content, including through academic (peer-reviewed) 
publication. Contractual clauses that limit the dissem-
ination of potentially critical findings—such as DFID’s 
new standard terms and conditions for service contracts 
(including evaluations), which prevent researchers from 
embarrassing DFID or bringing it into disrepute20—
should be deleted, since these terms jeopardise the inde-
pendence of evaluation and research.
For each study, an independent research oversight 
committee should be established. The committee should 
include a broad range of stakeholders to avoid institu-
tional bias and linkages with key funders, as well as fairly 
selected representatives from the communities that 
are being studied or civil society organisations who can 
assess the potential benefits and risks generated by the 
research. A key mandate of oversight committees would 
be to identify potential conflicts of interests and develop 
guidelines on rules of engagement between the commis-
sioners and researchers. Such committees should be in a 
position to intervene or arbitrate if conflict arises, such 
as if the commissioner or implementing partners pres-
sure, harass or threaten researchers, or if implementing 
partners feel that the researchers have misrepresented, 
traduced or misunderstood their work.
To prevent undue influence, donor agencies who 
commission research and evaluations should develop 
strong accountability measures between their opera-
tional departments and their research and evaluation 
departments. For example, it is well known in clinical 
medicine that pharmaceutical industry-funded trials 
are more likely to produce positive, flattering results 
than are independently funded trials.21–25 It is time to 
debate this important issue in global health too and to 
ask the question as to whether donor agencies should 
issue tenders for, commission and oversee evaluation and 
research involving their own programmes or whether it 
would be better for an arm’s length body to do so. To 
increase transparency and reduce selective reporting of 
findings, we recommend establishing a global health 
evaluation registry, similar to existing clinical trial regis-
tries.12 26
researChers and researCh InsTITuTIons
Today, universities and research organisations across the 
world depend heavily on external funding from govern-
ment departments, private foundations and industry.2. 
Therefore, they have an important responsibility to 
prevent conflicts of interest in research contracts. While 
better core funding would strengthen research insti-
tutions’ power over their own research priorities, they 
must also seek new ways to protect themselves from 
interference from external funders. Senior leadership 
in academia has a responsibility to discuss and develop 
terms of research with both funders and implementers. 
They should scrutinise all grants carefully and refuse 
those that have unfavourable contractual provisions (eg, 
those that limit researchers from disseminating poten-
tially critical findings).
Senior leadership should also create a supportive, colle-
gial environment for all research staff facing attempts 
at censorship, including providing legal support when 
necessary and, ideally, referral to a cross-institutional or 
national ombudsperson who can serve as a reference 
point for particular research areas or disciplines. They 
should extend support to individuals subcontracted to 
conduct research on behalf of institutions, who may be 
in especially vulnerable positions.
In addition, senior leadership should encourage meth-
odological and disciplinary diversity to capture complexity 
and value the dissemination of both positive and negative 
research findings. Senior research staff being prepared 
to disseminate controversial and politically contentious 
analyses can pave the way for more junior researchers to 
do the same. Research ethics and integrity issues should 
be part of research training programmes. Research 
institutions can also provide researchers with access to 
mentors external to their research group, particularly 
for junior staff with soft funding. Unions can play an 
important role if institutional leadership fails.
eThICs and researCh governanCe CommITTees
Ethics committees play a crucial role in ensuring the 
independence and integrity of research. Researchers 
seek approval from ethics committees, usually both at 
their research institutions and in the countries in which 
research is undertaken. Such committees have a remit 
to safeguard ethical conduct of research and protect the 
rights and welfare of research subjects, and primarily draw 
on biomedical research paradigms to do so. Although 
research ethics committees do often consider the safety 
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risks posed to individual researchers (injury and incar-
ceration), they do not typically consider concerns about 
protecting the researchers from interference and threats 
to their credibility. Therefore, they could play a fuller 
role in helping researchers navigate related unforeseen 
ethical dilemmas that arise in the course of research. 
For example, they can provide guidance on whether 
to extend protections intended for individual research 
subjects (eg, to ‘do no harm’) to organisations. They could 
also advice researchers on how to balance their ethical 
obligations to research participants and their obligations 
to wider society in the face of pressure from vested inter-
ests.27
Ethics committees should have representation from 
different research fields, with members who are trained in 
the epistemological and methodological bases of different 
disciplines.28 In addition, procedures for ensuring the 
independence of ethics committees are vital to prevent a 
situation in which members’ close ties to senior manage-
ment, funders, ruling parties, governments or commer-
cial interests lead them to use regulatory frameworks to 
shut down ‘unfavourable’ or disruptive research.
University research governance offices, where they 
exist, can complement ethics committees by protecting 
the rights and welfare of researchers especially where 
research challenges powerful agendas. They can offer 
advice and arbitration assistance to researchers on 
conflicts of interest arising in relation to external research 
funding. They can monitor for instances of unethical 
practice to enable research institutions to push back if 
powerful external actors manipulate research ethics 
regulations to constrain the research process, as some 
British universities have done in the past.29 Research 
institutions should develop clear value statements and 
commit to implementing them through their ethics and 
governance protocols.
aCademIC journals and edITors
The current practice is that academic journals ask or 
expect authors to declare any conflicts of interest relating 
to a publication. Journals ought to be challenging of 
these statements and refrain from publishing what is 
stated by authors in cases when it is obvious there is a 
gross conflict. Additional conflict of interest statements 
should be required from any co-authors that are part of 
the funding organisation. This can prevent funders from 
putting pressure on researchers to be included as co-au-
thors of papers emanating from the research and use this 
role to influence how the results are reported.
Academic journal editors have considerable potential 
to contribute towards dismantling the ‘success cartel’ 
within global health, for example, by publishing nega-
tive findings, and encouraging papers that explain the 
‘hows and whys’ of both positive and negative findings.30 
This includes process evaluations and in-depth political 
and social analyses of global health policy and practice, 
especially when these challenge the status quo. Editors 
of academic journals that publish global health research 
and evaluations should create procedures to select diverse 
peer reviewers without a vested interest and support them 
to rigorously question manuscripts that present uncritical 
and unexplained success stories. Editors should ensure 
diversity among peer reviewers and moderate dialogue 
between authors and peer reviewers where, for example, 
junior authors can challenge unduly hostile or politi-
cally motivated reviews by senior academics. They should 
ideally invite commentaries and responses from donor 
agencies, NGOs, civil society members, policy makers 
and researchers from the countries in which research 
and evaluations have been commissioned.
ConClusIon
The tensions between research ethics and the wider 
politics of the global health field are increasingly recog-
nised. However, the repercussions of these tensions for 
individuals and research institutions need careful consid-
eration. While ‘rocking the boat’ is uncomfortable and 
may threaten individual career progression and research 
institutions’ external income, biased evidence can harm 
health programme beneficiaries and public trust in 
research. There are certainly no simple, fail-safe, techno-
cratic quick fixes to resolving issues of power and poli-
tics, but the ideas proposed here should at least create 
better relationships between the institutions involved in 
commissioning, undertaking and publishing research, 
and feed into more sophisticated and thoughtful mech-
anisms of accountability, which do not simply re-enforce 
existing frameworks that favour accountability towards 
donors. The ideas we propose should be considered 
within broader discussions on how to address north–
south power imbalances within the research community, 
and will hopefully catalyse wider action on protecting the 
independence of public universities and other research 
institutions globally. We believe this is necessary to enable 
researchers to hold power to account and advance 
informed and healthy debate on issues of public interest.
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